Jacques de Champlain

9.6k total citations
224 papers, 7.5k citations indexed

About

Jacques de Champlain is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Jacques de Champlain has authored 224 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Cardiology and Cardiovascular Medicine, 69 papers in Physiology and 43 papers in Molecular Biology. Recurrent topics in Jacques de Champlain's work include Heart Rate Variability and Autonomic Control (54 papers), Nitric Oxide and Endothelin Effects (42 papers) and Receptor Mechanisms and Signaling (26 papers). Jacques de Champlain is often cited by papers focused on Heart Rate Variability and Autonomic Control (54 papers), Nitric Oxide and Endothelin Effects (42 papers) and Receptor Mechanisms and Signaling (26 papers). Jacques de Champlain collaborates with scholars based in Canada, United States and France. Jacques de Champlain's co-authors include Réginald Nadeau, Julius Axelrod, Adil El Midaoui, Marie Reine Van Ameringen, Rong Wu, Lingyun Wu, Denis Cousineau, Lawrence R. Krakoff, Marc‐André Laplante and N. Yamaguchi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Jacques de Champlain

222 papers receiving 6.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques de Champlain Canada 49 3.4k 1.8k 1.7k 1.3k 1.0k 224 7.5k
Noboru Toda Japan 47 1.8k 0.6× 3.6k 2.1× 1.6k 0.9× 1.4k 1.1× 608 0.6× 211 7.2k
Robin L. Davisson United States 52 3.6k 1.1× 1.9k 1.1× 2.6k 1.5× 620 0.5× 1.3k 1.2× 117 8.1k
R. Clinton Webb United States 45 1.9k 0.6× 2.6k 1.5× 2.5k 1.4× 551 0.4× 1.1k 1.0× 207 6.9k
Geoffrey A. Head Australia 48 5.0k 1.5× 1.8k 1.0× 1.7k 1.0× 1.0k 0.8× 1.3k 1.3× 331 8.9k
Frans Boomsma Netherlands 53 5.9k 1.8× 1.2k 0.7× 2.2k 1.2× 630 0.5× 2.3k 2.3× 261 10.8k
Samuel H.H. Chan Taiwan 44 1.7k 0.5× 2.0k 1.2× 2.1k 1.2× 1.7k 1.3× 389 0.4× 263 6.6k
Yoshitaka Hirooka Japan 51 4.6k 1.4× 2.6k 1.5× 1.4k 0.8× 516 0.4× 988 1.0× 214 8.1k
Colin Sumners United States 57 5.3k 1.6× 1.3k 0.7× 4.7k 2.7× 2.2k 1.7× 2.1k 2.1× 281 10.4k
Pramod R. Saxena Netherlands 48 2.6k 0.8× 2.6k 1.5× 2.3k 1.3× 1.6k 1.2× 1.3k 1.2× 220 8.3k
Frans H. H. Leenen Canada 53 5.3k 1.6× 1.1k 0.6× 2.3k 1.3× 656 0.5× 2.6k 2.5× 298 8.9k

Countries citing papers authored by Jacques de Champlain

Since Specialization
Citations

This map shows the geographic impact of Jacques de Champlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques de Champlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques de Champlain more than expected).

Fields of papers citing papers by Jacques de Champlain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques de Champlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques de Champlain. The network helps show where Jacques de Champlain may publish in the future.

Co-authorship network of co-authors of Jacques de Champlain

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques de Champlain. A scholar is included among the top collaborators of Jacques de Champlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques de Champlain. Jacques de Champlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bakris, G., Luís M. Ruilope, Francesco Locatelli, et al.. (2007). Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. Kidney International. 72(7). 879–885. 76 indexed citations
2.
Midaoui, Adil El, et al.. (2006). Is there a role for reactive oxygen species in arterial medial elastocalcinosis?. Vascular Pharmacology. 46(3). 201–206. 8 indexed citations
3.
Huynh, Nelly, Gilles Lavigne, Paola A. Lanfranchi, Jacques Montplaisir, & Jacques de Champlain. (2006). The Effect of 2 Sympatholytic Medications—Propranolol and Clonidine—On Sleep Bruxism: Experimental Randomized Controlled Studies. SLEEP. 29(3). 307–316. 88 indexed citations
4.
Midaoui, Adil El & Jacques de Champlain. (2005). Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. Journal of Hypertension. 23(3). 581–588. 34 indexed citations
5.
Champlain, Jacques de, Rong Wu, Hélène Girouard, et al.. (2004). Oxidative Stress in Hypertension. Clinical and Experimental Hypertension. 26(7-8). 593–601. 168 indexed citations
6.
Racine, Normand, et al.. (2001). Therapeutic potential of angiotensin II receptor antagonists. Expert Opinion on Investigational Drugs. 10(9). 1687–1701. 12 indexed citations
7.
Lemay, Jacinthe, et al.. (2001). Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. Journal of Hypertension. 19(11). 1965–1973. 48 indexed citations
8.
Wu, Lingyun & Jacques de Champlain. (1999). Superoxide Anion-Induced Formation of Inositol Phosphates Involves Tyrosine Kinase Activation in Smooth Muscle Cells from Rat Mesenteric Artery. Biochemical and Biophysical Research Communications. 259(2). 239–243. 13 indexed citations
9.
Cardinal, René, et al.. (1998). Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate - salt hypertension. Canadian Journal of Physiology and Pharmacology. 76(6). 665–675. 7 indexed citations
10.
Godin‐Ribuot, Diane, Christophe Ribuot, Daniel Lamontagne, et al.. (1997). Reflex adrenal medullary secretion during coronary occlusion mediated by cardiac receptors with afferent vagal fibres in the rat. Pflügers Archiv - European Journal of Physiology. 434(2). 159–165. 3 indexed citations
11.
Poulat, P., Jacques de Champlain, & Réjean Couture. (1996). Cardiovascular responses to intrathecal neuropeptide γ in conscious rats: receptor characterization and mechanism of action. British Journal of Pharmacology. 117(2). 250–257. 10 indexed citations
12.
Champlain, Jacques de, et al.. (1994). Effects of trandolapril on the sympathetic tone and reactivity in systemic hypertension. The American Journal of Cardiology. 73(10). C18–C25. 10 indexed citations
13.
Chahine, Ramez, Réginald Nadeau, Daniel Lamontagne, N. Yamaguchi, & Jacques de Champlain. (1994). Norepinephrine and dihydroxyphenylglycol effluxes from sympathetic nerve endings during hypoxia and reoxygenation in the isolated rat heart. Canadian Journal of Physiology and Pharmacology. 72(6). 595–601. 13 indexed citations
14.
Derchi, Giorgio, Jocelyn Dupuis, Jacques de Champlain, & Jean-Lucien Rouleau. (1993). Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure. European Heart Journal. 14(1). 34–39. 11 indexed citations
15.
Gaspo, Rania, et al.. (1992). Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogs. Canadian Journal of Physiology and Pharmacology. 70(7). 983–989. 2 indexed citations
16.
Chahine, Ramez, Mircea‐Alexandru Mateescu, Sébastien Roger, et al.. (1991). Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. Canadian Journal of Physiology and Pharmacology. 69(10). 1459–1464. 23 indexed citations
17.
Rouleau, Jean L., et al.. (1989). The use of angiotensin-converting enzyme inhibitors in congestive heart failure. Cardiovascular Drugs and Therapy. 3(6). 883–890. 2 indexed citations
18.
Rouleau, Jean‐Lucien, et al.. (1987). Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. Journal of the American College of Cardiology. 9(3). 622–630. 70 indexed citations
19.
Cléroux, Jean, François Péronnet, & Jacques de Champlain. (1987). Effects of exercise training on plasma catecholamines and blood pressure in labile hypertensive subjects. European Journal of Applied Physiology. 56(5). 550–554. 9 indexed citations
20.
Champlain, Jacques de, Denis Cousineau, & Luc Lapointe. (1978). The role of the sympathetic system in the maintenance of human hypertension.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(3-4). 123–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026